Literature DB >> 10731450

Deletion in the cardiac troponin I gene in a family from northern Sweden with hypertrophic cardiomyopathy.

S Mörner1, P Richard, E Kazzam, B Hainque, K Schwartz, A Waldenström.   

Abstract

The cardiac troponin I gene has been described to be associated with hypertrophic cardiomyopathy. Until now, mutations in this gene have been found only in the Japanese population. We now present the first non-Japanese family, from northern Sweden, with a mutation in the cardiac troponin I gene. Clinical diagnose was based on echocardiography, with a maximum left ventricular wall thickness of >13 mm, or major electrocardiographic abnormalities, excluding subjects with other known causes of cardiac hypertrophy. Mutation screening was performed with a single-strand conformation polymorphism analysis and identification of mutation by direct DNA sequencing. We have identified a 33-bp deletion in exon 8 encompassing the stop codon. Nine individuals in three generations were tested, and four were carriers of this deletion. The mother was genetically affected and died of heart failure aged 90. Echocardiography at 71 years of age revealed no hypertrophy, but the electrocardiogram showed signs of left ventricular hypertrophy. Her two sons, also genetically affected, had left ventricular hypertrophy, with maximum wall thickness of 15 and 16 mm, respectively. One daughter and four grandchildren were clinically unaffected, but one of them, a 27-year-old woman with maximum wall thickness of 8 mm and normal electrocardiogram, was found to be genetically affected. In conclusion, we describe a non-Japanese family in which hypertrophic cardiomyopathy is due to a genetic defect in the cardiac troponin I gene. This mutation is a deletion of 33 bp in the last exon, whereas the previously described mutations in this gene are single nucleotide changes and a single codon deletion. The deletion of the C-terminal part of the cardiac troponin I protein, seems in this particular family to be associated with a mild phenotypic expression of familial hypertrophic cardiomyopathy. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10731450     DOI: 10.1006/jmcc.1999.1099

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  11 in total

1.  Transgenic rabbit model for human troponin I-based hypertrophic cardiomyopathy.

Authors:  Atsushi Sanbe; Jeanne James; Volkan Tuzcu; Selman Nas; Lisa Martin; James Gulick; Hanna Osinska; Sadayappan Sakthivel; Raisa Klevitsky; Kenneth S Ginsburg; Donald M Bers; Bruce Zinman; Edward G Lakatta; Jeffrey Robbins
Journal:  Circulation       Date:  2005-05-02       Impact factor: 29.690

2.  Two mutations in troponin I that cause hypertrophic cardiomyopathy have contrasting effects on cardiac muscle contractility.

Authors:  David Burton; Hassan Abdulrazzak; Adam Knott; Kathryn Elliott; Charles Redwood; Hugh Watkins; Steven Marston; Chris Ashley
Journal:  Biochem J       Date:  2002-03-01       Impact factor: 3.857

3.  Calcium-regulated conformational change in the C-terminal end segment of troponin I and its binding to tropomyosin.

Authors:  Zhiling Zhang; Shirin Akhter; Steven Mottl; Jian-Ping Jin
Journal:  FEBS J       Date:  2011-08-16       Impact factor: 5.542

4.  Molecular Diagnosis of Primary Cardiomyopathy in 231 Unrelated Pediatric Cases by Panel-Based Next-Generation Sequencing: A Major Focus on Five Carriers of Biallelic TNNI3 Pathogenic Variants.

Authors:  Alexandre Janin; Thomas Perouse de Montclos; Karine Nguyen; Emilie Consolino; Gwenael Nadeau; Gaelle Rey; Océane Bouchot; Patricia Blanchet; Quentin Sabbagh; Cécile Cazeneuve; Rajae El-Malti; Elodie Morel; Antoine Delinière; Philippe Chevalier; Gilles Millat
Journal:  Mol Diagn Ther       Date:  2022-07-15       Impact factor: 4.476

5.  Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations.

Authors:  Jens Mogensen; Toru Kubo; Mauricio Duque; William Uribe; Anthony Shaw; Ross Murphy; Juan R Gimeno; Perry Elliott; William J McKenna
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

6.  Structural and kinetic effects of hypertrophic cardiomyopathy related mutations R146G/Q and R163W on the regulatory switching activity of rat cardiac troponin I.

Authors:  Zhiqun Zhou; Daniel Rieck; King-Lun Li; Yexin Ouyang; Wen-Ji Dong
Journal:  Arch Biochem Biophys       Date:  2012-12-13       Impact factor: 4.013

7.  Mutation of the MYH7 gene in a child with hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome.

Authors:  Waldemar Bobkowski; Małgorzata Sobieszczańska; Anna Turska-Kmieć; Agnieszka Nowak; Józef Jagielski; Marzena Gonerska; Arleta Lebioda; Aldona Siwińska
Journal:  J Appl Genet       Date:  2007       Impact factor: 3.240

8.  Impaired relaxation is the main manifestation in transgenic mice expressing a restrictive cardiomyopathy mutation, R193H, in cardiac TnI.

Authors:  Jianfeng Du; Jing Liu; Han-Zhong Feng; M M Hossain; Nariman Gobara; Chi Zhang; Yuejin Li; Pierre-Yves Jean-Charles; Jian-Ping Jin; Xu-Pei Huang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-04-11       Impact factor: 4.733

9.  Functional consequences of the human cardiac troponin I hypertrophic cardiomyopathy mutation R145G in transgenic mice.

Authors:  Yuhui Wen; Jose Renato Pinto; Aldrin V Gomes; Yuanyuan Xu; Yingcai Wang; Ying Wang; James D Potter; W Glenn L Kerrick
Journal:  J Biol Chem       Date:  2008-04-22       Impact factor: 5.157

10.  Disruption of Caenorhabditis elegans muscle structure and function caused by mutation of troponin I.

Authors:  A K Burkeen; S L Maday; K K Rybicka; J A Sulcove; J Ward; M M Huang; R Barstead; C Franzini-Armstrong; T StC Allen
Journal:  Biophys J       Date:  2004-02       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.